CD47 and neoplasm: They also showed that treatment with CD47 mAb impaired tumor growth and prolonged the survival of NSG mice bearing human H82 cell line xenografts, and that genetic ablation of CD47 in the KP1 model impaired tumor growth in immunodeficient and immunocompetent mice.